Welcome to our dedicated page for Microchip Technology SEC filings (Ticker: MCHP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Microchip Technology Inc. (NASDAQ: MCHP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed information about its semiconductor business, governance and financial condition. As a Delaware corporation headquartered in Chandler, Arizona, Microchip reports as a public company on the Nasdaq Global Select Market, and its regulatory filings are a primary source for understanding MCHP stock.
On this page, investors can review Microchip’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its role as a broadline supplier of semiconductors serving industrial, automotive, consumer, aerospace and defense, communications and computing markets. These reports typically include discussions of segment performance, risk factors, research and development, and other disclosures relevant to the company’s embedded control and semiconductor portfolio.
Microchip also submits current reports on Form 8-K to announce material events. For example, an 8-K dated November 6, 2025 reports the announcement of results for the second quarter of fiscal year 2026, while an 8-K dated August 20, 2025 details the outcomes of the company’s annual meeting of stockholders, including director elections, auditor ratification and an advisory vote on executive compensation.
Definitive proxy statements on Form DEF 14A provide insight into Microchip’s governance, board composition, executive compensation and stockholder voting procedures. The July 7, 2025 proxy statement outlines the agenda for the 2025 annual meeting, the proposals presented to stockholders and information about how to vote.
Stock Titan’s SEC filings page surfaces these documents as they are made available on EDGAR and can pair them with AI-powered summaries that explain key points, such as changes in guidance, voting results or governance matters. Users can quickly locate Forms 10-K, 10-Q, 8-K and DEF 14A related to Microchip Technology, helping them analyze MCHP’s regulatory history, monitor material events and understand the disclosures that shape the company’s profile in the semiconductor industry.
Microchip Technology Senior VP and CFO James Eric Bjornholt reported indirect open-market sales of a total of 5,530 shares of common stock held by a trust associated with him. The sales on February 24, 2026 occurred at prices of $77.09 and $78.93 per share under a pre-arranged Rule 10b5-1 trading plan adopted on May 23, 2025. After these transactions, 28,142 shares were reported as indirectly held.
Microchip Technology Inc. reported a Form 144 notice of intended sale of common stock, filed on
The filing lists the broker as Merrill Lynch and identifies NASDAQ as the market.
Microchip Technology's chief operating officer Richard J. Simoncic reported equity award activity rather than open‑market trading. On February 15 and 16, 2026, restricted stock units and performance stock units vested and were converted into shares of common stock, with vested shares delivered to him or an associated trust.
The filing shows multiple exercise or conversion (code M) transactions at a reference price of
Microchip Technology Inc. director, president, CEO and chair Steve Sanghi reported equity award vesting and related share movements. On
According to the footnotes, the resulting common shares are held indirectly by entities such as The Sanghi Trust and The Sanghi Family Limited Partnership, which held 9,911,806 shares as of
Microchip Technology senior vice president Joseph R. Krawczyk II reported multiple stock-based compensation transactions involving restricted stock units and common shares. On
Some of the newly delivered shares were automatically disposed of under transaction code F, which indicates shares were withheld to pay taxes or exercise-related obligations, rather than sold in an open-market trade. After these transactions, Krawczyk directly held 13,547 shares of Microchip Technology common stock.
Microchip Technology senior vice president of operations Mathew B. Bunker reported equity award activity tied to vesting restricted stock units (RSUs) and performance stock units (PSUs) on
Some of the newly delivered shares were automatically withheld at a price of
Microchip Technology Senior VP and CFO James Eric Bjornholt reported multiple equity award vesting transactions in mid-February 2026. Restricted stock units and performance stock units converted into common stock on
The vested shares were delivered to him upon vesting, and many are held indirectly through a trust. Several F-code transactions show small share dispositions used to satisfy tax withholding obligations rather than open‑market selling. Following these transactions, the trust held 33,672 shares of Microchip common stock.
Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 94,869 shares of common stock on February 12, 2026 at an average price of $82.4631 per share. The transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on June 6, 2025.
Following this sale, Sanghi is reported as indirectly beneficially owning 9,827,450 Microchip shares, held through The Sanghi Trust and The Sanghi Family Limited Partnership. These holdings reflect his ongoing indirect equity interest in the company he leads.
Microchip Technology executive Joseph R. Krawczyk II, Senior Vice President of Worldwide Client Engagement, reported an open-market sale of 4,400 shares of common stock on February 12, 2026 at an average price of $78.578 per share. After this transaction, he directly beneficially owned 12,781 shares of Microchip Technology common stock.